DXCM DexCom

$89.71 +0.02%

Updated 16 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

DexCom (DXCM) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $33.9 billion. Shares last traded at $89.71, 3.1% below their 52-week high. Over the past year the stock is up 19.1%. DXCM trades at a price-to-earnings ratio of 33.86, above the Surgical & Medical Instruments & Apparatus median of 28.18. Net profit margin is 20.1%, above the peer median of -9.3%. Revenue grew 15.6% year over year.

Market Cap

$33.9B

Shares Out

377.4M

EPS (TTM)

$3.79

P/E Ratio

23.67

P/S Ratio

6.81

P/B Ratio

12.91

Dividend / Share

—

Dividend Yield

—

52-Week High

$92.58

52-Week Low

$54.12

Volume

82,339

Avg Vol (3m)

260,787.587

Performance

+0.52%

+8.54%

+22.18%

+22.79%

YTD

+34.84%

+19.11%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

59.27

SMA (50)

$80.83

SMA (200)

$70.59

Price vs SMA50

+10.98%

Price vs SMA200

+27.09%

ATR (14)

$2.44

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$5.0B

Net Income

$1000M

Gross Margin

62.5%

Operating Margin

22.9%

Net Margin

20.1%

Return on Equity

38.1%

Return on Assets

15.5%

Current Ratio

1.73

Debt / Equity

0.00

Revenue Growth (YoY)

+15.6%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$1.15	2026-07-30
Q1 2026	$0.51	2026-04-30
FY 2025	$2.09	2026-02-12
Q3 2025	$1.42	2025-10-30
Q2 2026	$0.71	2026-07-30
Q1 2026	$0.27	2026-04-30

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

DXCM vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 16 d ago

P/E vs peers

33.86 / 28.18 med

+20% premium

P/S vs peers

6.81 / 2.94 med

+132% premium

Net margin vs peers

20.1% / -9.3% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.